The CRISPR-Cas system has facilitated the rapid production of targeted cell-lines, expanding drug discovery and development assay capabilities. This rapid production of new cell lines creates a need to quickly perform model generation and validation workflows, while still performing other cell-based assays. Download this white paper to about how the combination of the CRISPR-Cas system and a modern plate reader, such as the Spark® Cyto, can drive your research forward by:
- Allowing multiple samples to be processed simultaneously
- Facilitating multiple readings through an experimental time course
- Providing advanced environmental controls
